Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $53.3B |
| FY2017, ended Dec 31, 2017 | $83.3B |
| FY2018, ended Dec 31, 2018 | $117B |
| FY2019, ended Dec 31, 2019 | $142B |
| FY2020, ended Dec 31, 2020 | $239B |
| FY2021, ended Dec 31, 2021 | $267B |
| FY2022, ended Dec 31, 2022 | $131B |
| FY2023, ended Dec 31, 2023 | $211B |
| FY2024, ended Dec 31, 2024 | $381B |
| FY2025, ended Dec 31, 2025 | $396B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $286B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.83B |
| FY2017, ended Dec 31, 2017 | $11.7B |
| FY2018, ended Dec 31, 2018 | $15.8B |
| FY2019, ended Dec 31, 2019 | $20.2B |
| FY2020, ended Dec 31, 2020 | $25.0B |
| FY2021, ended Dec 31, 2021 | $29.7B |
| FY2022, ended Dec 31, 2022 | $31.6B |
| FY2023, ended Dec 31, 2023 | $33.7B |
| FY2024, ended Dec 31, 2024 | $39.0B |
| FY2025, ended Dec 31, 2025 | $45.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $49.7B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $187M | −$1.58B |
| FY2017, ended Dec 31, 2017 | $559M | −$1.96B |
| FY2018, ended Dec 31, 2018 | $1.21B | −$2.85B |
| FY2019, ended Dec 31, 2019 | $1.87B | −$3.14B |
| FY2020, ended Dec 31, 2020 | $2.76B | $1.93B |
| FY2021, ended Dec 31, 2021 | $5.12B | −$132M |
| FY2022, ended Dec 31, 2022 | $4.49B | $1.62B |
| FY2023, ended Dec 31, 2023 | $5.41B | $6.93B |
| FY2024, ended Dec 31, 2024 | $8.71B | $6.92B |
| FY2025, ended Dec 31, 2025 | $11.0B | $9.46B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $14.8B | $11.4B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.47B |
| FY2017, ended Dec 31, 2017 | $2.82B |
| FY2018, ended Dec 31, 2018 | $3.79B |
| FY2019, ended Dec 31, 2019 | $5.02B |
| FY2020, ended Dec 31, 2020 | $8.21B |
| FY2021, ended Dec 31, 2021 | $6.03B |
| FY2022, ended Dec 31, 2022 | $5.15B |
| FY2023, ended Dec 31, 2023 | $7.12B |
| FY2024, ended Dec 31, 2024 | $7.80B |
| FY2025, ended Dec 31, 2025 | $9.03B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $8.19B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.36B |
| FY2017, ended Dec 31, 2017 | $9.05B |
| FY2018, ended Dec 31, 2018 | $14.9B |
| FY2019, ended Dec 31, 2019 | $20.7B |
| FY2020, ended Dec 31, 2020 | $22.4B |
| FY2021, ended Dec 31, 2021 | $15.4B |
| FY2022, ended Dec 31, 2022 | $14.4B |
| FY2023, ended Dec 31, 2023 | $14.5B |
| FY2024, ended Dec 31, 2024 | $15.6B |
| FY2025, ended Dec 31, 2025 | $14.5B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $15.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 4.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 4.30B |
| FY2017, ended Dec 31, 2017 | 4.34B |
| FY2018, ended Dec 31, 2018 | 4.37B |
| FY2019, ended Dec 31, 2019 | 4.39B |
| FY2020, ended Dec 31, 2020 | 4.43B |
| FY2021, ended Dec 31, 2021 | 4.44B |
| FY2022, ended Dec 31, 2022 | 4.45B |
| FY2023, ended Dec 31, 2023 | 4.33B |
| FY2024, ended Dec 31, 2024 | 4.28B |
| FY2025, ended Dec 31, 2025 | 4.22B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 4.11B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $174M | $37.0M |
| FY2017, ended Dec 31, 2017 | — | $182M | $88.4M |
| FY2018, ended Dec 31, 2018 | — | $321M | $125M |
| FY2019, ended Dec 31, 2019 | $0 | $405M | $72.5M |
| FY2020, ended Dec 31, 2020 | $0 | $415M | $235M |
| FY2021, ended Dec 31, 2021 | $600M | $403M | $174M |
| FY2022, ended Dec 31, 2022 | $0 | $575M | — |
| FY2023, ended Dec 31, 2023 | $6.05B | $339M | — |
| FY2024, ended Dec 31, 2024 | $6.26B | $273M | — |
| FY2025, ended Dec 31, 2025 | $9.13B | $368M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $12.9B | $540M | — |
Valuation
At current price- Market Cap
- $257B
- P/E
- 17.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.2×
- Price / Book
- 8.8×
- EV / EBITDA
- 16.5×
Growth
Trailing 12 months- Revenue (TTM)
- $49.7B
- Revenue Growth YoY
- 14.7%
- Revenue CAGR 3Y
- 12.6%
- Revenue CAGR 5Y
- 12.6%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 41.6%
Profitability
Trailing 12 months- Gross Margin
- 50.7%
- Operating Margin
- 31.3%
- Net Margin
- 29.7%
- FCF Margin
- 22.9%
- Return on Equity
- 53.5%
Earnings
Trailing 12 months- Net Income
- $14.8B
- EPS (diluted)
- $3.46
- EBITDA
- $16.0B
- Operating Income
- $15.6B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $8.19B
- Total Debt
- $15.1B
- Net Debt
- $6.94B
- Total Assets
- $58.7B
- Total Liabilities
- $29.4B
- Shareholders' Equity
- $29.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $12.3B
- Capital Expenditure
- $933M
- Free Cash Flow
- $11.4B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.61
Every ratio is calculated from the company’s reported figures.